Topic Introduction

Systematic Mapping of Chemical–Genetic Interactions in Saccharomyces cerevisiae

  1. Robert P. St.Onge1,4
  1. 1Stanford Genome Technology Center, Department of Biochemistry, Stanford University, Palo Alto, California 94304;
  2. 2Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064;
  3. 3Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada

    Abstract

    Chemical–genetic interactions (CGIs) describe a phenomenon where the effects of a chemical compound (i.e., a small molecule) on cell growth are dependent on a particular gene. CGIs can reveal important functional information about genes and can also be powerful indicators of a compound’s mechanism of action. Mapping CGIs can lead to the discovery of new chemical probes, which, in contrast to genetic perturbations, operate at the level of the gene product (or pathway) and can be fast-acting, tunable, and reversible. The simple culture conditions required for yeast and its rapid growth, as well as the availability of a complete set of barcoded gene deletion strains, facilitate systematic mapping of CGIs in this organism. This process involves two basic steps: first, screening chemical libraries to identify bioactive compounds affecting growth and, second, measuring the effects of these compounds on genome-wide collections of mutant strains. Here, we introduce protocols for both steps that have great potential for the discovery and development of new small-molecule tools and medicines.

    Footnotes

    • 4 Correspondence: bstonge{at}stanford.edu

    No Related Web Pages
    | Table of Contents